Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

ClinicalTrials.gov ID: NCT06113445

Public ClinicalTrials.gov record NCT06113445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 12:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Study identification

NCT ID
NCT06113445
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
467 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2023 (Actual)
Primary completion
Feb 24, 2026 (Actual)
Completion
Feb 24, 2027 (Estimated)
Last update posted
Aug 25, 2026

2023 – 2027

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
Cahaba Dermatology Hoover Alabama 35244 —
University of California Irvine Irvine California 92697 —
Clinical Science Institute Clinical Research Specialists Inc Santa Monica California 90404 —
Cura Clinical Research Sherman Oaks California 91403 —
Sutter Health Palo Alto Medical Foundation Pamf Sunnyvale Center Sunnyvale California 94086 —
Renaissance Research Cape Coral Florida 33991 —
Encore Medical Research, Llc Hollywood Florida 33021 —
Savin Medical Group, Rc Miami Florida 33156 —
Skin Research of South Florida, Llc Miami Florida 33173 —
San Marcus Research Clinic Inc. Miami Lakes Florida 33014 —
Olympian Clinical Research Tampa Florida 33609 —
Forcare Clinical Research Tampa Florida 33613 —
Cleaver Medical Group Cumming Georgia 30040 —
Dermatology and Surgery Specialists of North Atlanta Marietta Georgia 30068 —
Pivotal Research Solutions Stonecrest Georgia 30038 —
Options Research Group, Llc Kokomo Indiana 46901 —
Allcutis Research, Llc Beverly Massachusetts 01915 —
Metro Boston Clinical Partners Brighton Massachusetts 02135-3511 —
Great Lakes Research Group Inc Bay City Michigan 48706 —
Wayne State University Physician Group Dermatology Dearborn Michigan 48124 —
Revival Research Institute, Llc Dermatology Troy Michigan 48084 —
Medisearch Clinical Trials Saint Joseph Missouri 64506 —
Jdr Dermatology Research Las Vegas Nevada 89148 —
Empire Dermatology East Syracuse New York 13057 —
Sadick Dermatology Sadick Research Group New York New York 10075 —
Derm Research Center of New York Inc Stony Brook New York 11790 —
Dermatology Associates of Plymouth Meeting Plymouth Meeting Pennsylvania 19462 —
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130 —
University of Texas Physicians - Bellaire Station Bellaire Texas 77401 —
Center For Clinical Studies Houston Texas 77004 —
Progressive Clinical Research San Antonio Texas 78213 —
Jordan Valley Dermatology Center West Jordan Utah 84088 —
Clinical Research Partners Llc Crp Richmond Forest Avenue Office Building Location Richmond Virginia 23226 —
Dermatology Specialists of Spokane Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06113445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06113445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →